Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CAROLYN M DILLARD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1396790721
CMS profile
335773
Location
VAN BUREN, AR

General Payments · PY2018–2024

$3,807.06

  • Reported across 145 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,063.01

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,063.01 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $431.51 8
Acerta Pharma LLC $198.54 7
Lilly USA, LLC $136.19 11
Gilead Sciences, Inc. $124.97 1
Exact Sciences Corporation $65.92 4
Amgen Inc. $36.02 2
DEXCOM, INC. $28.98 1
PFIZER INC. $20.94 1
Novo Nordisk AS $19.94 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $281.39 12
PY2019 $543.85 15
PY2020 $329.03 14
PY2021 $193.73 4
PY2022 $616.01 29
PY2023 $780.04 35
PY2024 $1,063.01 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $125.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 1103642544 CMS
ABBVIE INC. $10.38 05/01/2024 Food and Beverage Undisputed 01/23/2026 1103642546 CMS
ABBVIE INC. $12.00 05/06/2024 Food and Beverage Undisputed 01/23/2026 1103642548 CMS
ABBVIE INC. $8.09 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103642550 CMS
ABBVIE INC. $124.83 06/04/2024 Food and Beverage Undisputed 01/23/2026 1103642552 CMS
ABBVIE INC. $6.28 06/04/2024 Food and Beverage Undisputed 01/23/2026 1103642554 CMS
ABBVIE INC. $125.00 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103642556 CMS
ABBVIE INC. $19.93 09/30/2024 Food and Beverage Undisputed 01/23/2026 1103642558 CMS
Amgen Inc. $14.82 02/28/2024 Food and Beverage Undisputed 01/23/2026 1117239529 CMS
Amgen Inc. $21.20 09/25/2024 Food and Beverage Undisputed 01/23/2026 1117239531 CMS
AstraZeneca Pharmaceuticals LP $14.73 01/19/2024 Food and Beverage Undisputed 01/23/2026 1104685035 CMS
AstraZeneca Pharmaceuticals LP $107.05 02/05/2024 Food and Beverage Undisputed 01/23/2026 1104201453 CMS
AstraZeneca Pharmaceuticals LP $16.54 02/28/2024 Food and Beverage Undisputed 01/23/2026 1104553586 CMS
AstraZeneca Pharmaceuticals LP $13.34 05/15/2024 Food and Beverage Undisputed 01/23/2026 1105777258 CMS
AstraZeneca Pharmaceuticals LP $14.85 05/23/2024 Food and Beverage Undisputed 01/23/2026 1105585412 CMS
AstraZeneca Pharmaceuticals LP $15.78 06/28/2024 Food and Beverage Undisputed 01/23/2026 1104541924 CMS
AstraZeneca Pharmaceuticals LP $16.25 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104261693 CMS
Dexcom, Inc. $28.98 05/29/2024 Food and Beverage Undisputed 01/23/2026 1153290371 CMS
Exact Sciences Corporation $14.62 02/15/2024 Food and Beverage Undisputed 01/23/2026 1114637149 CMS
Exact Sciences Corporation $13.66 04/15/2024 Food and Beverage Undisputed 01/23/2026 1114637156 CMS
Exact Sciences Corporation $13.47 09/24/2024 Food and Beverage Undisputed 01/23/2026 1114637161 CMS
Exact Sciences Corporation $24.17 11/07/2024 Food and Beverage Undisputed 01/23/2026 1114637167 CMS
Gilead Sciences, Inc. $124.97 05/30/2024 Food and Beverage Undisputed 01/23/2026 1133635363 CMS
Lilly USA, LLC $10.22 01/24/2024 Food and Beverage Undisputed 01/23/2026 1136087950 CMS
Lilly USA, LLC $11.09 02/13/2024 Food and Beverage Undisputed 01/23/2026 1136087884 CMS
Lilly USA, LLC $19.91 03/05/2024 Food and Beverage Undisputed 01/23/2026 1136087882 CMS
Lilly USA, LLC $8.32 03/06/2024 Food and Beverage Undisputed 01/23/2026 1136087952 CMS
Lilly USA, LLC $12.12 04/17/2024 Food and Beverage Undisputed 01/23/2026 1136087326 CMS
Lilly USA, LLC $9.43 05/21/2024 Food and Beverage Undisputed 01/23/2026 1136091804 CMS
Lilly USA, LLC $13.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 1136087328 CMS
Lilly USA, LLC $10.95 09/09/2024 Food and Beverage Undisputed 01/23/2026 1136084668 CMS
Lilly USA, LLC $14.01 09/25/2024 Food and Beverage Undisputed 01/23/2026 1136091802 CMS
Lilly USA, LLC $10.60 10/07/2024 Food and Beverage Undisputed 01/23/2026 1136087886 CMS
Lilly USA, LLC $15.66 10/29/2024 Food and Beverage Undisputed 01/23/2026 1136087330 CMS
Novo Nordisk Inc $19.94 02/09/2024 Food and Beverage Undisputed 01/23/2026 1097210974 CMS
PFIZER INC. $20.94 11/25/2024 Food and Beverage Undisputed 01/23/2026 1131109364 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.